Enrico Giraudo
Enrico Giraudo
Candiolo Cancer Institute, FPO- IRCCS, and Dept. of Science e Drug Technology, University of Torino
Verified email at ircc.it - Homepage
TitleCited byYear
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
E Giraudo, M Inoue, D Hanahan
The Journal of clinical investigation 114 (5), 623-633, 2004
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
JA Joyce, A Baruch, K Chehade, N Meyer-Morse, E Giraudo, FY Tsai, ...
Cancer cell 5 (5), 443-453, 2004
The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells
A Albini, R Soldi, D Giunciuclio, E Giraudo, R Benelli, L Primo, D Noonan, ...
Nature medicine 2 (12), 1371-1375, 1996
Modeling the early stages of vascular network assembly
G Serini, D Ambrosi, E Giraudo, A Gamba, L Preziosi, F Bussolino
The EMBO journal 22 (8), 1771-1779, 2003
Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells
E Giraudo, L Primo, E Audero, HP Gerber, P Koolwijk, S Soker, ...
Journal of Biological Chemistry 273 (34), 22128-22135, 1998
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
JA Hoffman, E Giraudo, M Singh, L Zhang, M Inoue, K Porkka, D Hanahan, ...
Cancer cell 4 (5), 383-391, 2003
Percolation, morphogenesis, and Burgers dynamics in blood vessels formation
A Gamba, D Ambrosi, A Coniglio, A De Candia, S Di Talia, E Giraudo, ...
Physical review letters 90 (11), 118101, 2003
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models
F Maione, F Molla, C Meda, R Latini, L Zentilin, M Giacca, G Seano, ...
The Journal of clinical investigation 119 (11), 3356-3372, 2009
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
F Maione, S Capano, D Regano, L Zentilin, M Giacca, O Casanovas, ...
The Journal of clinical investigation 122 (5), 1832-1848, 2012
In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis
F Silvagno, A Follenzi, M Arese, M Prat, E Giraudo, G Gaudino, ...
Arteriosclerosis, thrombosis, and vascular biology 15 (11), 1857-1865, 1995
Src‐mediated activation of α‐diacylglycerol kinase is required for hepatocyte growth factor‐induced cell motility
S Cutrupi, G Baldanzi, D Gramaglia, A Maffè, D Schaap, E Giraudo, ...
The EMBO Journal 19 (17), 4614-4622, 2000
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer
D Daniel, C Chiu, E Giraudo, M Inoue, LA Mizzen, NR Chu, D Hanahan
Cancer research 65 (5), 2018-2025, 2005
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ...
Nature 552 (7683), 116, 2017
Temporal and Spatial Modulation of Rho GTPases during in Vitro Formation of Capillary Vascular Network ADHERENS JUNCTIONS AND MYOSIN LIGHT CHAIN AS TARGETS OF Rac1 AND RhoA
I Cascone, E Giraudo, F Caccavari, L Napione, E Bertotti, JG Collard, ...
Journal of Biological Chemistry 278 (50), 50702-50713, 2003
Lymphatic zip codes in premalignant lesions and tumors
L Zhang, E Giraudo, JA Hoffman, D Hanahan, E Ruoslahti
Cancer Research 66 (11), 5696-5706, 2006
The role of semaphorins and their receptors in vascular development and cancer
C Gu, E Giraudo
Experimental cell research 319 (9), 1306-1316, 2013
AP-2α and AP-2γ regulate tumor progression via specific genetic programs
F Orso, E Penna, D Cimino, E Astanina, F Maione, D Valdembri, ...
The FASEB Journal 22 (8), 2702-2714, 2008
Tie-2–dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1
I Cascone, E Audero, E Giraudo, L Napione, F Maniero, MR Philips, ...
Blood 102 (7), 2482-2490, 2003
Tumour growth inhibition and anti‐metastatic activity of a mutated furin‐resistant Semaphorin 3E isoform
A Casazza, B Kigel, F Maione, L Capparuccia, O Kessler, E Giraudo, ...
EMBO molecular medicine 4 (3), 234-250, 2012
IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells.
E Giraudo, M Arese, C Toniatti, M Strasly, L Primo, A Mantovani, ...
The Journal of Immunology 157 (6), 2618-2623, 1996
The system can't perform the operation now. Try again later.
Articles 1–20